通过采访,探索药剂师对不合格和伪造医疗产品的看法
A Persson1, M Troein1, S Lundin2
1Center for Primary Health Care Research, Department of Clinical Sciences Malmö, Lund University, Box 50332, SE-20213 Malmö, Sweden.
Exploratory research in clinical and social pharmacy
|February 26, 2024
概括
药剂师可以作为对不合格和伪造 (SF) 医疗产品的监护人,特别是随着在线药品销售的增加. 他们的知识和沟通技巧是保护患者免受网上购买的不安全药物的关键.
科学领域:
- 制药科学 制药科学
- 公共卫生 公共卫生
- 药用化学 医学化学
背景情况:
- 药品电子商务的兴起带来了低质量和伪造 (SF) 医疗产品的风险越来越大,即使在高收入国家.
- 未经授权的在线药房经常提供质量可疑的药物,需要采取战略来防止这个问题升级.
- 医疗保健专业人员,特别是药剂师对SF医疗产品的知识和经验的理解有限.
研究的目的:
- 探索故意选择的药剂师关于不合格和伪造 (SF) 医疗产品的经验和知识.
- 鉴定药剂师在增加在线药品销售的背景下,可以在减轻与SF医疗产品相关的风险方面发挥的作用.
主要方法:
- 定性研究涉及十二个与选定的药剂师的个人访谈.
- 采访采用了一份以电子商务,药剂师经验和SF医疗产品知识为重点的指南.
- 数据使用诱导性定性内容分析来分析.
主要成果:
- 从分析中出现了一个核心主题",药剂师作为安全药物的守护者".
- 确定的关键类别包括风险因素,保护因素和与SF医疗产品相关的改进机会.
- 药剂师的发现表明他们有潜力防止SF医疗产品问题的升级,这是由对患者安全的承诺所驱动的.
结论:
- 药剂师在教育公众关于SF医疗产品的风险方面处于有利地位,因为他们经常与患者互动.
- 利用风险因素的认识,药剂师可以引导患者远离从未经授权的网站购买药物.
- 加强药剂师,患者和其他医疗保健专业人员之间的沟通和协作对于解决SF医疗产品威胁至关重要.
相关概念视频
01:19Pharmacovigilance
833
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
833
01:25Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
01:28Biopharmaceutics and Pharmacokinetics: Overview
2.0K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
2.0K
01:03Drug Control Governance: Regulatory Bodies and Their Impact
158
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
158
01:26Drug Administration and Therapy Phases: Overview
465
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
465
01:15Drug Abuse and Addiction: Pharmacological Phenomena
476
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
476